Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 37.
. lappuse
... Clinical Physiology - Fifth Edition , $ 5.00 , express prepaid . The author gives evidence of high scholarly attainments , pene- trating intelligence , admirable industry , along with that necessary quality in any pioneer work , intense ...
... Clinical Physiology - Fifth Edition , $ 5.00 , express prepaid . The author gives evidence of high scholarly attainments , pene- trating intelligence , admirable industry , along with that necessary quality in any pioneer work , intense ...
ii. lappuse
... Clinical Dentistry 6e Oxford Handbook of Clinical Diagnosis 3e Oxford Handbook of Clinical Examination and Practical Skills 2e Oxford Handbook of Clinical Haematology 3e Oxford Handbook of Clinical Immunology and Allergy 3e Oxford ...
... Clinical Dentistry 6e Oxford Handbook of Clinical Diagnosis 3e Oxford Handbook of Clinical Examination and Practical Skills 2e Oxford Handbook of Clinical Haematology 3e Oxford Handbook of Clinical Immunology and Allergy 3e Oxford ...
ix. lappuse
... Clinical Specialties, the Oxford Assess and Progress Clinical Specialties volume seeks to tie together the clinical specialties and to provide a grounding in know- ledge that may get pushed to the back burner when medicine and surgery ...
... Clinical Specialties, the Oxford Assess and Progress Clinical Specialties volume seeks to tie together the clinical specialties and to provide a grounding in know- ledge that may get pushed to the back burner when medicine and surgery ...
11. lappuse
... clinical subjects only from the viewpoint of an expert in the given field. This monograph is unique in that it excludes this one-sidedness; by combining the experience of a diagnostic radiologist with a clinical endocrinologist, this ...
... clinical subjects only from the viewpoint of an expert in the given field. This monograph is unique in that it excludes this one-sidedness; by combining the experience of a diagnostic radiologist with a clinical endocrinologist, this ...
. lappuse
... Clinical Lecture 214 353 15 , 126 Clinical Demonstration at the Medical Graduates ' College and Polyclinic ... Clinical Lecture on Raynaud's Phenomena ... Two Clinical Lectures on Intestinal Ulceration KELLOCK , THOMAS H. , M.A. ...
... Clinical Lecture 214 353 15 , 126 Clinical Demonstration at the Medical Graduates ' College and Polyclinic ... Clinical Lecture on Raynaud's Phenomena ... Two Clinical Lectures on Intestinal Ulceration KELLOCK , THOMAS H. , M.A. ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning